| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 9.5 | 23.9 | 309 | 153.7 | - | - | - | 496.0 |
| - | - | - | 2 | 8.7 | 77.4 | 36.3 | - | - | - | 124.5 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 4,350 | 98.6% | -2.00 | 1,089 | 98.2% |
| Optic-unspecified(L) | 63 | 1.4% | -1.66 | 20 | 1.8% |
| upstream partner | # | NT | conns Cm22 | % In | CV |
|---|---|---|---|---|---|
| MeTu3b (L) | 35 | ACh | 94.8 | 20.0% | 0.7 |
| MeVPMe10 (R) | 2 | Glu | 63.6 | 13.4% | 0.0 |
| Cm-DRA (L) | 4 | ACh | 59.3 | 12.5% | 0.3 |
| Dm-DRA1 (L) | 24 | Glu | 49.3 | 10.4% | 0.4 |
| MeTu3a (L) | 20 | ACh | 43.7 | 9.2% | 0.5 |
| Cm14 (L) | 22 | GABA | 33.6 | 7.1% | 0.5 |
| Mi15 (L) | 104 | ACh | 16.4 | 3.5% | 0.5 |
| MeTu3c (L) | 36 | ACh | 14.7 | 3.1% | 1.4 |
| MeTu2a (L) | 32 | ACh | 10.4 | 2.2% | 0.6 |
| MeVP31 (L) | 1 | ACh | 10.3 | 2.2% | 0.0 |
| Cm31b (L) | 1 | GABA | 9.8 | 2.1% | 0.0 |
| Cm20 (L) | 10 | GABA | 9.7 | 2.0% | 1.0 |
| Cm11d (L) | 7 | ACh | 9 | 1.9% | 0.8 |
| aMe9 (L) | 2 | ACh | 6.9 | 1.5% | 0.2 |
| aMe17e (L) | 1 | Glu | 5.3 | 1.1% | 0.0 |
| Cm21 (L) | 10 | GABA | 4.4 | 0.9% | 0.6 |
| Tm39 (L) | 13 | ACh | 3.7 | 0.8% | 0.6 |
| MeVC22 (L) | 2 | Glu | 3.3 | 0.7% | 0.4 |
| aMe17a (L) | 1 | unc | 3.2 | 0.7% | 0.0 |
| Cm18 (L) | 7 | Glu | 3.2 | 0.7% | 0.8 |
| MeVC2 (R) | 1 | ACh | 1.7 | 0.4% | 0.0 |
| Cm6 (L) | 8 | GABA | 1.7 | 0.4% | 0.6 |
| Cm3 (L) | 9 | GABA | 1.4 | 0.3% | 0.5 |
| Cm4 (L) | 9 | Glu | 1.2 | 0.3% | 0.3 |
| MeVP12 (L) | 4 | ACh | 1.1 | 0.2% | 0.8 |
| aMe5 (L) | 2 | ACh | 1 | 0.2% | 0.6 |
| MeTu2b (L) | 6 | ACh | 1 | 0.2% | 0.3 |
| aMe26 (L) | 3 | ACh | 0.9 | 0.2% | 0.6 |
| ME_LO_unclear (L) | 1 | unc | 0.8 | 0.2% | 0.0 |
| Dm2 (L) | 5 | ACh | 0.7 | 0.1% | 0.3 |
| Mi10 (L) | 6 | ACh | 0.7 | 0.1% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.6 | 0.1% | 0.0 |
| MeVP14 (L) | 4 | ACh | 0.6 | 0.1% | 0.3 |
| R7d | 2 | HA | 0.4 | 0.1% | 0.0 |
| MeVC27 (R) | 2 | unc | 0.4 | 0.1% | 0.5 |
| Cm8 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| MeTu1 (L) | 2 | ACh | 0.3 | 0.1% | 0.3 |
| MeVC11 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP15 (L) | 3 | ACh | 0.3 | 0.1% | 0.0 |
| MeVC21 (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| Cm28 (L) | 3 | Glu | 0.3 | 0.1% | 0.0 |
| Dm-DRA2 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| aMe4 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Cm9 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Tm4 (L) | 2 | ACh | 0.2 | 0.0% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo3b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm22 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVPLo2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| R7p | 1 | HA | 0.1 | 0.0% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo6 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi18 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm22 | % Out | CV |
|---|---|---|---|---|---|
| MeTu2a (L) | 34 | ACh | 107.7 | 27.1% | 0.4 |
| Cm14 (L) | 24 | GABA | 38.8 | 9.8% | 0.3 |
| MeTu2b (L) | 15 | ACh | 35.6 | 8.9% | 0.3 |
| Cm4 (L) | 100 | Glu | 35.6 | 8.9% | 0.6 |
| Mi15 (L) | 195 | ACh | 35.3 | 8.9% | 0.6 |
| Cm35 (L) | 1 | GABA | 29.8 | 7.5% | 0.0 |
| Cm21 (L) | 11 | GABA | 23.6 | 5.9% | 0.5 |
| MeTu3c (L) | 46 | ACh | 16 | 4.0% | 0.6 |
| MeTu3a (L) | 20 | ACh | 14.4 | 3.6% | 0.4 |
| Dm-DRA1 (L) | 20 | Glu | 9.1 | 2.3% | 0.9 |
| MeVPMe3 (L) | 1 | Glu | 6.4 | 1.6% | 0.0 |
| aMe4 (L) | 9 | ACh | 4.4 | 1.1% | 0.5 |
| MeTu3b (L) | 19 | ACh | 3.3 | 0.8% | 0.6 |
| Cm-DRA (L) | 4 | ACh | 3.1 | 0.8% | 0.6 |
| MeVP15 (L) | 12 | ACh | 2.8 | 0.7% | 0.7 |
| MeVC22 (L) | 2 | Glu | 2.7 | 0.7% | 0.2 |
| Cm30 (L) | 2 | GABA | 2.4 | 0.6% | 0.1 |
| Cm32 (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| aMe5 (L) | 6 | ACh | 1.8 | 0.4% | 0.3 |
| Cm31b (L) | 1 | GABA | 1.4 | 0.4% | 0.0 |
| Cm18 (L) | 6 | Glu | 1.3 | 0.3% | 0.5 |
| MeVPMe4 (L) | 2 | Glu | 1.2 | 0.3% | 0.3 |
| MeVP12 (L) | 3 | ACh | 1.1 | 0.3% | 0.3 |
| MeVPMe10 (L) | 2 | Glu | 1 | 0.3% | 0.6 |
| Cm20 (L) | 7 | GABA | 1 | 0.3% | 0.4 |
| MeVC20 (L) | 2 | Glu | 0.9 | 0.2% | 0.2 |
| Cm17 (L) | 3 | GABA | 0.8 | 0.2% | 0.5 |
| Tm37 (L) | 6 | Glu | 0.8 | 0.2% | 0.3 |
| MeVP31 (L) | 1 | ACh | 0.8 | 0.2% | 0.0 |
| Cm3 (L) | 6 | GABA | 0.8 | 0.2% | 0.3 |
| MeTu1 (L) | 5 | ACh | 0.7 | 0.2% | 0.3 |
| Cm11a (L) | 1 | ACh | 0.6 | 0.1% | 0.0 |
| Cm8 (L) | 4 | GABA | 0.6 | 0.1% | 0.3 |
| Mi1 (L) | 5 | ACh | 0.6 | 0.1% | 0.0 |
| l-LNv (L) | 3 | unc | 0.4 | 0.1% | 0.4 |
| Cm5 (L) | 3 | GABA | 0.4 | 0.1% | 0.4 |
| Cm28 (L) | 3 | Glu | 0.4 | 0.1% | 0.4 |
| MeVP39 (L) | 1 | GABA | 0.4 | 0.1% | 0.0 |
| Pm12 (L) | 2 | GABA | 0.3 | 0.1% | 0.3 |
| Tm32 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| TmY3 (L) | 3 | ACh | 0.3 | 0.1% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm30 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm5a (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Dm2 (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Cm12 (L) | 2 | GABA | 0.2 | 0.1% | 0.0 |
| Tm5Y (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Cm11d (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| aMe12 (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| aMe9 (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Cm9 (L) | 2 | Glu | 0.2 | 0.1% | 0.0 |
| TmY17 (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Tm5c (L) | 2 | Glu | 0.2 | 0.1% | 0.0 |
| Cm10 (L) | 2 | GABA | 0.2 | 0.1% | 0.0 |
| Cm13 (L) | 2 | Glu | 0.2 | 0.1% | 0.0 |
| Tm6 (L) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Mi17 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm7 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| R7d | 1 | HA | 0.1 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ME_unclear (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Pm13 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm5b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP14 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe5 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| T2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP8 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP35 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi14 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm35 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi16 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm22 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm24 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm34 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |